Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
The biopharma world's manufacturing weekly
Manufacturing channel feed
CDMOs anticipate inspection bottlenecks after mass FDA firings
3 months ago
FDA+
Novartis follows Lilly and J&J in announcing multibillion-dollar US manufacturing investment
3 months ago
Pharma
Pharma tariffs: Here’s what a potential rollout could look like
3 months ago
Pharma
DHL pours €2B into healthcare logistics; OXB revenues on the rise
3 months ago
Novo Nordisk looks to Brazil to boost GLP-1 manufacturing with $1B+ budget
3 months ago
Pharma
Updated: Pharma is next in line as Trump says tariffs are coming 'very shortly'
3 months ago
Pharma
Pharma CEOs warn EU of potential ‘exodus to the US’ as trade war continues
3 months ago
Pharma
Drug tool and packaging makers to feel brunt of Trump tariffs, analysts say
3 months ago
Pharma
Cell and gene therapy CDMO AmplifyBio shuts down over 'scarcity' of funding
3 months ago
Cell/Gene Tx
China's retaliatory tariffs on US could mean more headwinds for drugmakers
3 months ago
China
Pharma
SHL Medical opens $220M autoinjector site; DHL acquires clinical trial firm
3 months ago
Chaotic tariff rollout leaves as many questions as answers for drugmakers
3 months ago
Pharma
Trump’s broad tariffs exempt pharma — but for how long?
3 months ago
Pharma
FDA+
New CDMO emerges, acquires cell and gene manufacturer Landmark Bio
3 months ago
Deals
Cell/Gene Tx
Milestone's shares dive after FDA again rejects drug for abnormal heart rhythm
3 months ago
Pharma
With tariffs on the way, generic drugmaking woes could hinder Trump’s reshoring plan
3 months ago
Pharma
Chiesi pours €430 into new Italy site; Bharat’s first CGT site in India
3 months ago
WuXi Biologics’ licensing deals help offset Biosecure threat in the US
3 months ago
Deals
China
Three major questions on pharma tariffs Trump claims are on the way
3 months ago
Pharma
Liver cancer drug combo gets second FDA rejection over manufacturing issues
3 months ago
Pharma
FDA+
AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in China
3 months ago
R&D
China
Johnson & Johnson earmarks $55B to boost US capacity
3 months ago
Pharma
Merck to lay off 163 workers in Pennsylvania; Delpharm gets $60M from Canadian government
3 months ago
WuXi AppTec's US revenue growth continues to dip in post-Biosecure environment
3 months ago
China
Pharma
First page
Previous page
1
2
3
4
5
6
7
Next page
Last page
